Aurobindo Pharma Stocks Up 4%
Aurobindo Pharma’s shares has gained 4 per cent to Rs 1,003.75 on the BSE in the intra-day deal on Friday after the drug firm announced...
Tag : Aurobindo Pharma
Nifty Pharma Climbs 3% After RBI Announces Liquidity
Nifty Pharma stocks were in fast lane on Wednesday tracking all market clues. The performance in pharma stocks comes after when the RBI Governor Shaktikanta...
Indian Equity Market Continues To Rise For Seven Straight Days
Indian equity markets continued their record-breaking run, extending their winning streak for the seventh straight day, ending at another record high. The S&P BSE Sensex...
Aurobindo Pharma Gets VAI Classification From USFDA
Aurobindo Pharma said the US health regulator has decided that the inspection classification of company’s injectable formulation manufacturing facility at Hyderabad is voluntary action...
Aurobindo Pharma Receives Final Approval From US FDA
One of India’s leading drug-maker, Aurobindo Pharma has obtained the final approval from the US health regulator for its Azithromycin oral suspension used for the...
Aurobindo Pharma To Buy Parts Of Sandoz US
The Swiss drugmaker, Novartis AG, said in a statement to the press that it would sell the dermatology and generic US oral solids portfolios of...
Aurobindo Pharma to acquire Apotex operations in 5 European countries
Aurobindo Pharma has signed definitive agreement to acquire from Apotex International Inc, its commercial operations and certain supporting infrastructure in five European countries, for 74 million euros....
Aurobindo Pharma gets USFDA approval for Azithromycin tablets
Aurobindo Pharma has received final approval to manufacture and market Azithromycin tablets, from the USFDA. The tablets are used for the treatment of patients with mild...
Aurobindo Pharma gets USFDA approval to market Ibuprofen capsules
Aurobindo Pharma has received final approval to manufacture and market Ibuprofen capsules. The approval has been received from the US health regulator. In a BSE filing the...
Aurobindo Pharma receives USFDA nod for Ertapenem injection
Aurobindo Pharma has received USFDA’s go ahead, for Ertapenem injection. Ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz injection and the...